SCHEMBL30037664

SCHEMBL30037664

O=C(Nc1ccc(F)cc1)c1cccc(CCO)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.69
▸ KMT2A Q03164 6/20 0.69
▸ NPC1 O15118 3/20 0.58
▸ RAB9A P51151 3/20 0.58
▸ CXCR2 P25025 1/20 0.54
▸ POLB P06746 3/20 0.52
▸ CYP4F2 P78329 1/20 0.52
▸ CYP4A11 Q02928 1/20 0.52
▸ KCNK3 O14649 1/20 0.52
▸ KCNK9 Q9NPC2 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ KDM1A O60341 1/20 0.52
▸ MAOB P27338 1/20 0.52
▸ HTR2B P41595 1/20 0.52
▸ CTDSP1 Q9GZU7 1/20 0.51
▸ PTPN1 P18031 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ MITF O75030 1/20 0.49
▸ TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696431 0.87 MEN1 (0.68) MEN1KMT2ANPC1RAB9ACXCR2
SCHEMBL29994466 0.87 HDAC8 (0.59) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL15676725 0.84 MEN1 (0.71) MEN1KMT2ANPC1RAB9ACXCR2
SCHEMBL8867655 0.82 PTPN1 (0.65) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL1690510 0.81 MEN1 (0.66) MEN1KMT2ANPC1RAB9ACXCR2
SCHEMBL30739642 0.80 KMT2A (0.86) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL19157408 0.78 MEN1 (0.51) MEN1KMT2ANPC1RAB9AKDM1A
SCHEMBL10804897 0.77 MEN1 (0.81) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL3992218 0.76 KMT2A (0.57) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL7235790 0.76 MEN1 (0.84) MEN1KMT2ANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096661-A1 COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS Kamari Pharma Ltd. (IL) 2022-12-07 — — EP disclosed
Send feedback